- Home
- BEP vs HALO Comparison
BEP vs HALO Comparison
Compare BEP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEP
- HALO
- Stock Information
- Founded
- BEP 1999
- HALO 1998
- Country
- BEP Canada
- HALO United States
- Employees
- BEP N/A
- HALO N/A
- Industry
- BEP Electric Utilities: Central
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BEP Utilities
- HALO Health Care
- Exchange
- BEP Nasdaq
- HALO Nasdaq
- Market Cap
- BEP 7.3B
- HALO 7.6B
- IPO Year
- BEP N/A
- HALO N/A
- Fundamental
- Price
- BEP $25.32
- HALO $76.90
- Analyst Decision
- BEP Buy
- HALO Buy
- Analyst Count
- BEP 8
- HALO 8
- Target Price
- BEP $31.25
- HALO $70.25
- AVG Volume (30 Days)
- BEP 428.2K
- HALO 2.0M
- Earning Date
- BEP 11-07-2025
- HALO 10-30-2025
- Dividend Yield
- BEP 5.82%
- HALO N/A
- EPS Growth
- BEP N/A
- HALO 68.93
- EPS
- BEP N/A
- HALO 4.37
- Revenue
- BEP $6,174,000,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- BEP $18.12
- HALO $32.57
- Revenue Next Year
- BEP $5.94
- HALO $23.25
- P/E Ratio
- BEP N/A
- HALO $17.62
- Revenue Growth
- BEP 12.75
- HALO 34.97
- 52 Week Low
- BEP $19.29
- HALO $42.01
- 52 Week High
- BEP $29.56
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- BEP 50.70
- HALO 77.94
- Support Level
- BEP $24.48
- HALO $74.52
- Resistance Level
- BEP $25.50
- HALO $76.28
- Average True Range (ATR)
- BEP 0.43
- HALO 1.63
- MACD
- BEP 0.05
- HALO -0.06
- Stochastic Oscillator
- BEP 55.63
- HALO 88.60
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.